These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26947399)

  • 41. Molecular epidemiology and clinical features of hand, foot and mouth disease in northern Thailand in 2016: a prospective cohort study.
    Upala P; Apidechkul T; Suttana W; Kullawong N; Tamornpark R; Inta C
    BMC Infect Dis; 2018 Dec; 18(1):630. PubMed ID: 30522440
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
    Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N
    Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [C3d enhances immune response to the secreted form of Coxsackie virus B3 VP1 DNA vaccine].
    Zhao N; Han XY; Wang XL; Li J; Li W; Xie LX; Li L; Wang YX
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2561-3. PubMed ID: 18067834
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses.
    Chapman NM; Tu Z; Tracy S; Gauntt CJ
    Arch Virol; 1994; 135(1-2):115-30. PubMed ID: 8198437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A group B coxsackievirus/poliovirus 5' nontranslated region chimera can act as an attenuated vaccine strain in mice.
    Chapman NM; Ragland A; Leser JS; Höfling K; Willian S; Semler BL; Tracy S
    J Virol; 2000 May; 74(9):4047-56. PubMed ID: 10756016
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coxsackievirus B3-induced myocarditis. Characterization of stable attenuated variants that protect against infection with the cardiovirulent wild-type strain.
    Zhang H; Morgan-Capner P; Latif N; Pandolfino YA; Fan W; Dunn MJ; Archard LC
    Am J Pathol; 1997 Jun; 150(6):2197-207. PubMed ID: 9176409
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Simultaneous Point-of-Care Detection of Enterovirus 71 and Coxsackievirus B3.
    Wang JJ; Jiang YZ; Lin Y; Wen L; Lv C; Zhang ZL; Chen G; Pang DW
    Anal Chem; 2015 Nov; 87(21):11105-12. PubMed ID: 26461918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Seroprevalence of group B Coxsackieviruses: Retrospective study in an Italian population.
    Sciandra I; Falasca F; Maida P; Tranquilli G; Di Carlo D; Mazzuti L; Melengu T; Giannelli G; Antonelli G; Turriziani O
    J Med Virol; 2020 Dec; 92(12):3138-3143. PubMed ID: 32531866
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Seroepidemiology of Enterovirus 71 infection prior to the 2011 season in children in Shanghai.
    Zeng M; El Khatib NF; Tu S; Ren P; Xu S; Zhu Q; Mo X; Pu D; Wang X; Altmeyer R
    J Clin Virol; 2012 Apr; 53(4):285-9. PubMed ID: 22265829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spontaneous C-cleavage of a truncated intein as fusion tag to produce tag-free VP1 inclusion body nanoparticle vaccine against CVB3-induced viral myocarditis by the oral route.
    Qi X; Lu Q; Hu J; Xiong S
    Microb Cell Fact; 2019 Apr; 18(1):66. PubMed ID: 30947747
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MCPIP1 inhibits coxsackievirus B3 replication by targeting viral RNA and negatively regulates virus-induced inflammation.
    Li M; Yan K; Wei L; Yang Y; Qian Q; Xu W
    Med Microbiol Immunol; 2018 Feb; 207(1):27-38. PubMed ID: 29043433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis and solution of false-positives when testing CVA16 sera using an antibody assay against the EV71 virus.
    Wang C; You A; Tian X; Zhao M; Chen Y; Lin T; Zheng J; Xiao M; Zhang Y; Kuang L; Zhou Z; Zhu B
    Virus Res; 2013 Sep; 176(1-2):33-6. PubMed ID: 23707400
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis.
    Henke A; Zell R; Ehrlich G; Stelzner A
    J Virol; 2001 Sep; 75(17):8187-94. PubMed ID: 11483764
    [TBL] [Abstract][Full Text] [Related]  

  • 54. AIM2 Co-immunization with VP1 Is Associated with Increased Memory CD8 T Cells and Mounts Long Lasting Protection against Coxsackievirus B3 Challenge.
    Yin L; Chai D; Yue Y; Dong C; Xiong S
    Front Cell Infect Microbiol; 2017; 7():247. PubMed ID: 28642849
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interferon-beta expression and type I interferon receptor signaling of hepatocytes prevent hepatic necrosis and virus dissemination in Coxsackievirus B3-infected mice.
    Koestner W; Spanier J; Klause T; Tegtmeyer PK; Becker J; Herder V; Borst K; Todt D; Lienenklaus S; Gerhauser I; Detje CN; Geffers R; Langereis MA; Vondran FWR; Yuan Q; van Kuppeveld FJM; Ott M; Staeheli P; Steinmann E; Baumgärtner W; Wacker F; Kalinke U
    PLoS Pathog; 2018 Aug; 14(8):e1007235. PubMed ID: 30075026
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Study on combined immunization of rAd/MDC-VP1 and pcDNA3/MDC-VP1 against Coxsackievirus B3 challenge in mice].
    Yan LJ; Gao ZY; Li J; Lan JM; Jin YH; Xie LX; Chuai X; Wang YX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Mar; 28(3):228-31. PubMed ID: 22394627
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge.
    Kim JY; Jeon ES; Lim BK; Kim SM; Chung SK; Kim JM; Park SI; Jo I; Nam JH
    Vaccine; 2005 Feb; 23(14):1672-9. PubMed ID: 15705471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Severe atypical hand-foot-and-mouth disease in adults due to coxsackievirus A6: Clinical presentation and phylogenesis of CV-A6 strains.
    Broccolo F; Drago F; Ciccarese G; Genoni A; Puggioni A; Rosa GM; Parodi A; Manukyan H; Laassri M; Chumakov K; Toniolo A
    J Clin Virol; 2019 Jan; 110():1-6. PubMed ID: 30472520
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
    Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
    Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simultaneous determination of human Enterovirus 71 and Coxsackievirus B3 by dual-color quantum dots and homogeneous immunoassay.
    Chen L; Zhang X; Zhou G; Xiang X; Ji X; Zheng Z; He Z; Wang H
    Anal Chem; 2012 Apr; 84(7):3200-7. PubMed ID: 22390751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.